What this means in plain English:
PANS and PANDAS describe the same core clinical picture — a sudden immune-triggered neuropsychiatric episode in a child — but they differ in their trigger. PANDAS requires strep. PANS can be triggered by any of more than 20 infections or inflammatory events. That distinction determines which tests your provider should order and shapes the treatment approach.
Last reviewed by Mary Margaret Burch, FNP-BC, FMAPS — August 2026
Most parents in this community encounter PANS and PANDAS as though they are interchangeable — two names for the same condition, used depending on which clinician you are seeing or which parent community you are in. That is understandable. The symptom picture is nearly identical. The underlying biological mechanism is similar. And many clinicians use PANS as an umbrella term that encompasses PANDAS.
But the distinction carries real clinical weight. The trigger determines the testing, and the testing determines whether the cause of the episode is identified and treated. A child with PANDAS who is only evaluated for non-strep triggers may never get the strep treatment that resolves the flare. A child with PANS triggered by mycoplasma who is only tested for strep may keep having episodes because the actual trigger is never identified. The difference between the two diagnoses is where the infection investigation starts — and that matters enormously for families who have been cycling through episodes without resolution.
PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. It was the first of the two conditions identified — originally described through research at the National Institute of Mental Health in the 1990s — and it has the most defined biological mechanism.
In PANDAS, a Group A Streptococcal infection triggers the immune system to produce antibodies that cross-react with structures in the basal ganglia — a region of the brain involved in movement, habit formation, and the regulation of obsessive-compulsive behavior. This process is called molecular mimicry: the antibodies are designed to fight strep, but because strep proteins resemble certain brain proteins, the antibodies also attack neuronal tissue.
Key features of PANDAS:
PANS — Pediatric Acute-onset Neuropsychiatric Syndrome — was defined to capture children who presented with the same clinical picture as PANDAS but whose episodes were triggered by infections other than strep. PANS is not a replacement for PANDAS. It is a broader category that PANDAS fits within.
The trigger list for PANS includes more than 20 potential infections and inflammatory events:
Because the trigger is broader, the testing workup is also broader — and identifying the specific trigger is important for targeted treatment.
| Feature | PANDAS | PANS |
|---|---|---|
| Trigger | Group A Streptococcus only | Any infection or inflammatory event (20+ triggers) |
| Seasonal pattern | Often fall and winter (strep season) | Year-round, depending on trigger |
| First symptoms | OCD and tics are most common first presentation | Anxiety and personality change often appear first |
| Key blood tests | ASO titer, anti-DNase B titer, throat culture | Broad infectious panel: mycoplasma, Lyme, viral titers, plus strep tests |
| Antibiotic approach | Strep-targeted antibiotics (penicillin, amoxicillin, azithromycin) | Depends on identified trigger; may require different antibiotic class |
| Relationship | A subset of PANS | The broader category that includes PANDAS |
One of the most common patterns in families who cycle through PANS/PANDAS episodes without resolution is inadequate trigger identification. The episodes are recognized and partially treated, but the specific infection driving them is never confirmed — and without that confirmation, treatment cannot be fully targeted.
This matters because different triggers require different treatments. A child with PANDAS who responds to strep-targeted antibiotics may have a straightforward path to episode resolution. A child with PANS triggered by mycoplasma requires antibiotics effective against mycoplasma, which are a different class. A child whose episodes are driven by Lyme disease requires a completely different treatment pathway.
The clinical goal is not to label the condition — it is to identify the trigger, treat it appropriately, and develop a prophylaxis plan that reduces the frequency of future episodes.
These are examples of questions you might consider raising. This section is for education only.
"My child's episodes don't seem to be tied to strep. What other infections should we be testing for, and what does that workup look like?"
Why this works: It moves the conversation beyond strep testing to the broader trigger investigation that PANS requires.
"We have treated strep but my child is still having episodes. Is it possible there is a different trigger we haven't identified yet?"
Why this works: It raises the possibility of an unidentified PANS trigger without dismissing the strep work that has already been done.
"If we identify the specific trigger, what does the treatment and prophylaxis plan look like going forward?"
Why this works: It focuses the conversation on the goal — not just identifying the trigger but building a plan to reduce future episodes.
If this helped you see your child's behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don't have to navigate autism and PANS/PANDAS care alone. Join the learning community
Yes. PANDAS is a specific subset of PANS. All children who meet PANDAS criteria also meet PANS criteria. The reverse is not true: not all children with PANS have PANDAS, because their trigger may not be strep.
Yes. Some children have episodes triggered by strep and separate episodes triggered by other infections. Tracking which infections precede which episodes over time helps build a clearer picture of the individual child's trigger profile — which is why a detailed episode log is valuable.
Mycoplasma does not need to enter the brain to trigger neuropsychiatric symptoms. The immune response to the infection produces antibodies and cytokines that can cross the blood-brain barrier and cause neuroinflammation, similar to the mechanism in PANDAS. The infection is in the lungs or sinuses; the neurological effects are the result of the immune response.
PANS and PANDAS are clinical diagnoses — not confirmed by a single test. A provider who is familiar with these conditions can begin evaluation and treatment based on the clinical picture and the results of the infectious workup. A formal diagnostic label is less important than identifying the trigger and treating it appropriately.
No single test confirms either diagnosis. The Autoimmune Brain Panel (formerly known as the Cunningham Panel) measures autoantibodies against neuronal targets and can provide supportive biological evidence, but it is not a diagnostic test on its own. The diagnosis is built from the clinical history, the symptom cluster, the onset timeline, and the results of the infectious workup.
EDUCATIONAL CONTENT ONLY
This article is for educational purposes only. It does not constitute medical advice and does not create a provider-patient relationship between the reader and Mary Margaret Burch, FNP-BC, FMAPS, or Spectrum Care Hub LLC. Do not use this article to self-diagnose, self-treat, or make decisions about your child's care without consultation with a qualified, licensed healthcare provider.
Individual children vary significantly in their biology, presentation, and response to interventions. Response rates and outcomes described in this article reflect population-level research findings and do not predict results for any individual child.
Biomedical interventions discussed are presented as potentially complementary to — not replacements for — conventional medical care.
Last reviewed by Mary Margaret Burch, FNP-BC, FMAPS — August 2026.
© 2026 Spectrum Care Hub LLC. All rights reserved. 17 U.S.C. 101 et seq. Terms of Use | Privacy Policy